Day One (NASDAQ: DAWN) Names Jaa Roberson as Chief People Officer

South San Francisco, CA, September 13, 2021 – FlemingMartin, LLC is pleased to announce that Day One Biopharmaceuticals, a leading biopharma company on a mission to develop and advance novel cancer medicines with a focus on pediatric oncology, has hired Jaa Roberson to be their new Chief People Officer.

Further information can be found in GlobeNewswire: https://www.globenewswire.com/news-release/2021/09/13/2295604/0/en/Day-One-Appoints-Jaa-Roberson-as-Chief-People-Officer.html

Day One Biopharmaceuticals (NASDAQ: DAWN) is dedicated to finding and developing new therapies that meet the critical needs of people of all ages living with cancer – starting from the biology of childhood cancer. The Company’s distinctive approach, together with its trusted network of pediatric oncology investigators, gives Day One Bio an unparalleled ability to advance promising discoveries for patients of any age.

FlemingMartin, LLC, is a leading retained executive search firm with offices in Northern and Southern California. FlemingMartin partners with Boards, CEOs and Private Equity to build successful execution-focused management teams. FlemingMartin focuses in the Technology, Manufacturing, and Consumer Products & Services industries. The Firm’s principals are trusted advisors and business partners who enable companies to gain powerful, far-reaching, and lasting contributions from their executive-level human capital.